Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1996
12/24/1996US5587177 Medicament having a pediatric presentation for facilitating the ingestion thereof by a child
12/24/1996US5587176 Methods of using hesperetin for sebum control and treatment of acne
12/24/1996US5587175 Medical uses of in situ formed gels
12/24/1996US5587172 Process for forming quickly dispersing comestible unit and product therefrom
12/24/1996US5587153 Clear, gelled aluminum and zirconium salt containing antiperspirant formulation
12/24/1996US5587149 Polyethylene glycol in oil emulsion in gelatin capsules
12/24/1996US5587143 Adsorbed on surface
12/19/1996WO1996041368A1 Multilayer high vertical aspect ratio thin film structures
12/19/1996WO1996041236A1 Therapeutic microdevices and methods of making and using same
12/19/1996WO1996040964A2 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
12/19/1996WO1996040963A1 Cationic lipid:dna complexes for gene targeting
12/19/1996WO1996040962A1 Cationic lipid:dna complexes for gene targeting
12/19/1996WO1996040961A1 Peptide-enhanced cationic lipid transfections
12/19/1996WO1996040959A1 Cell line producing analgesic compounds for treating pain
12/19/1996WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA
12/19/1996WO1996040871A1 Bioartificial organs comprising open pored foam-like membranes
12/19/1996WO1996040829A1 Crosslinkable polypeptide compositions
12/19/1996WO1996040784A2 Method of solubilizing, purifying, and refolding protein
12/19/1996WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996WO1996040726A1 Novel carbamate-based cationic lipids
12/19/1996WO1996040725A1 Phosphonic acid-based cationic lipids
12/19/1996WO1996040627A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996WO1996040615A1 Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions
12/19/1996WO1996040502A1 Improved methods for the manufacture of magnetically responsive particles
12/19/1996WO1996040420A1 Micromachined porous membranes with bulksupport
12/19/1996WO1996040355A1 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
12/19/1996WO1996040334A1 Delivery of oxygen-supersaturated physiologic solutions
12/19/1996WO1996040265A1 Stabilization of polynucleotide complexes
12/19/1996WO1996040264A1 Separation of active complexes
12/19/1996WO1996040259A2 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
12/19/1996WO1996040243A1 Liposomes containing human immunodeficiency virus glycoprotein and methods for use thereof
12/19/1996WO1996040221A1 Wound healing formulations containing human plasma fibronectin
12/19/1996WO1996040217A1 Thrombopoietin compositions
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040192A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
12/19/1996WO1996040171A1 Intrauterine chemical necrosing method and composition
12/19/1996WO1996040169A1 Bacterial inhibition with an oligosaccharide compound
12/19/1996WO1996040166A1 Nucleotide analogues for topical treatment of proliferative disease of the skin
12/19/1996WO1996040163A1 Purified galactomannan as an improved pharmaceutical excipient
12/19/1996WO1996040149A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/19/1996WO1996040148A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/19/1996WO1996040144A1 Oral acyclovir delivery
12/19/1996WO1996040139A1 Novel formulations for transdermal delivery of pergolide
12/19/1996WO1996040103A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996WO1996040102A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996WO1996040090A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996WO1996040089A2 Aerosol drug formulations containing vegetable oils
12/19/1996WO1996040088A1 Acyclovir derivatives for topical use
12/19/1996WO1996040087A2 Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group
12/19/1996WO1996040086A2 Compositions and methods for topical administration of pharmaceutically active agents
12/19/1996WO1996040085A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/19/1996WO1996040084A1 Compositions and methods for use of pressure sensitive adhesive transdermal devices containing a bioadhesive humectant
12/19/1996WO1996040083A2 Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials
12/19/1996WO1996040082A2 Apparatus and method for delivering a biologically active compound into a biological environment
12/19/1996WO1996040081A2 Oral delivery of gene constructs
12/19/1996WO1996040080A1 Controlled release formulation having a preformed passageway
12/19/1996WO1996040079A1 Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
12/19/1996WO1996040078A1 Delivery of drugs to the lower gi tract
12/19/1996WO1996040077A2 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
12/19/1996WO1996040076A1 Spray drying method and apparatus
12/19/1996WO1996040075A1 Large scale production process with instantaneous component mixing and controlled sequential mixing characteristics
12/19/1996WO1996040074A2 Device for releasing aggregation-stabilized, biologically active agent
12/19/1996WO1996040073A2 Composition for sustained release of non-aggregated erythropoietin
12/19/1996WO1996040072A2 Composition for sustained release of human growth hormone
12/19/1996WO1996040071A1 Method for the manufacture of minimal volume capsules containing biological material
12/19/1996WO1996040070A1 Fragrances and flavorants
12/19/1996WO1996040069A1 System and method for producing drug-loaded microparticles
12/19/1996WO1996040068A1 Methods and system for processing dispersible fine powders
12/19/1996WO1996040067A1 Cationic lipid acid salt of 3 beta [n-(n',n'-dimethylaminoethane)-carbamoyl] cholesterol
12/19/1996WO1996040066A1 A METHOD FOR ELICITING A Th1-SPECIFIC IMMUNE RESPONSE
12/19/1996WO1996040065A1 Improved liposomal formulation
12/19/1996WO1996040064A1 Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
12/19/1996WO1996040063A1 Process for making liposome preparation
12/19/1996WO1996040062A1 A method of transfection of cells using liposomally encapsulated nucleic acids
12/19/1996WO1996040061A1 Method for encapsulating pharmaceutical materials
12/19/1996WO1996040060A1 Intracellular delivery of macromolecules
12/19/1996WO1996040059A1 Dinucleotides useful for the treatment of lung disease
12/19/1996WO1996040058A2 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
12/19/1996WO1996040057A2 Reverse fluorocarbon emulsion compositions for drug delivery
12/19/1996WO1996040056A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996WO1996040055A2 Biological agent compositions
12/19/1996WO1996040053A1 Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents
12/19/1996WO1996040052A1 Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
12/19/1996WO1996040051A1 Sustained release ophthalmic emulsions
12/19/1996WO1996040050A1 Oral dosage and method for treating painful conditions of the oral cavity
12/19/1996WO1996040049A1 Peptide/protein suspended formulations
12/19/1996WO1996040002A1 Vascularized tissue regeneration matrices formed by solid free-form fabrication methods
12/19/1996WO1996039995A1 High viscosity liquid controlled delivery system
12/19/1996WO1996039994A1 An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
12/19/1996WO1996039987A1 Locking couplings for osmotic delivery devices
12/19/1996WO1996039835A1 Method of solubilizing and encapsulating itraconazole
12/19/1996WO1996039831A1 Prodrugs of pharmaceuticals with improved bioavailability
12/19/1996WO1996036222A3 Improved method for controlling ectoparasites
12/19/1996DE19522899C1 Verfahren zum kontinuierlichen Ersintern eines Granulats Method for continuous sintering of granules
12/19/1996DE19521974A1 Pharmazeutische Zubereitung mit Cyclosporin A A pharmaceutical preparation containing cyclosporin A
12/19/1996DE19521684A1 Ophthalmic pharmaceutical composition
12/19/1996DE19521412A1 Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung New cationic and polycationic amphiphiles containing these reagents and their use
12/19/1996CA2236946A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996CA2224230A1 Oral acyclovir delivery
12/19/1996CA2224227A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
1 ... 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 ... 2991